SABER UCV >
1) Investigación >
Artículos Publicados >

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/123456789/6480

Título : TRATAMIENTO PRESERVADOR DEL CÁNCER DE LA MAMA. DOS AÑOS DE EXPERIENCIA
Autor : Bérgamo, Laura
Bolivar, Efren
Godoy, Ali Josue
Romero, Gabriel
Carrero, Nelly
Betancourt, Luis
Salas Rodriguez, Joanne
León, Juan G
Palabras clave : Cáncer, mama, tratamiento, preservador, evolución.
Cancer, breast, treatment, preserved, evolution.
Fecha de publicación : Mar-2011
Editorial : Rev Venez Oncol
Citación : BERGAMO, Laura et al. Tratamiento preservador del cáncer de la mama: Dos años de experiencia. Rev. venez. oncol. [online]. 2011, vol.23, n.1, pp. 46-49 .
Resumen : OBJECTIVE: Presented the experience in our institution in the conservative treatment of breast cancer, we analyzed the surgery, local recurrence, and the global super life, and the disease free survival. METHOD: These are a descriptive and retrospective study during 2004-2005 in patients underwent conservative treatment: Realize of partial oncology mastectomy with negative margins surgical evaluation of axillaries sentinel node technique or axillaries dissection. The adjuvant treatment with radiation therapy and chemotherapy when there are indicated in the patients. RESULTS: We realize 132 conservative surgery, median ages of patients were 51.49 histological type more frequent was ductal infiltrante carcinoma (70.06.%), (85.94 %) were stage I and II. The surgical more frequent were partial oncology mastectomy with axillaries dissection (80 patients, 61.87 %).10.6 % received adjuvant chemotherapy. The average of finding nodes was 11.37, the 62.6 % pathological axillaries state were 0.50.% expression positive estrogen and progestagen receptors 13.17 % super expression of Her2neu. 66.66 % received adjuvant chemotherapy, 79.84.% adjuvant radiation therapy 56.58 % adjuvant hormonal therapy. Average vigilance was 39.89 months. 88.88 % alive free disease, 2.22 % alive with local recurrence, and 5.92 % alive with metastases. 1.48 % alive with local and metastasis recurrence 1.07 % dead for disease. The free interval of disease was 25.8 month and the global super life to 5 years 98.24 %. CONCLUSIONS: The conservative treatment is a primary and effective in breast cancer therapy for stage I and II.
URI : http://saber.ucv.ve/jspui/handle/123456789/6480
ISSN : 0798-0582
Aparece en las colecciones: Artículos Publicados

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
tratamientopreservador2011.pdf192.77 kBAdobe PDFVisualizar/Abrir

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2008 MIT and Hewlett-Packard - Comentarios